BCG Tuberculosis (TB) Vaccine Market Report

BCG Tuberculosis (TB) Vaccine Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Jan 06, 2020
  • PAGES：210
  • REPORT CODE：GMM425912
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide BCG Tuberculosis (TB) Vaccine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.8% during the forecast period.

    This report presents the market size and development trends by detailing the BCG Tuberculosis (TB) Vaccine market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the BCG Tuberculosis (TB) Vaccine market will be shown in this report. In short, this report will comprehensively reveal the characteristics of BCG Tuberculosis (TB) Vaccine industry and will help you to build a panoramic view of the industrial development.

    BCG Tuberculosis (TB) Vaccine Market, By Type:

    • Immune BCG

    • Therapy BCG

    BCG Tuberculosis (TB) Vaccine Market, By Application:

    • Hospital

    • Clinic

    Some of the leading players are as follows:

    • GSBPL

    • Serum Institute of India

    • China National Biotec

    • Sanofi Pasteur

    • Intervax

    • Merck

    • Japan BCG Lab

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 BCG Tuberculosis (TB) Vaccine Market: Technology Type Analysis

    • 4.1 BCG Tuberculosis (TB) Vaccine Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 BCG Tuberculosis (TB) Vaccine Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Immune BCG

      • 4.3.2 Therapy BCG

    5 BCG Tuberculosis (TB) Vaccine Market: Product Analysis

    • 5.1 BCG Tuberculosis (TB) Vaccine Product Market Share Analysis, 2018 & 2026

    • 5.2 BCG Tuberculosis (TB) Vaccine Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 BCG Tuberculosis (TB) Vaccine Market: Application Analysis

    • 6.1 BCG Tuberculosis (TB) Vaccine Application Market Share Analysis, 2018 & 2026

    • 6.2 BCG Tuberculosis (TB) Vaccine Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Hospital

      • 6.3.2 Clinic

    7 BCG Tuberculosis (TB) Vaccine Market: Regional Analysis

    • 7.1 BCG Tuberculosis (TB) Vaccine Regional Market Share Analysis, 2018 & 2026

    • 7.2 BCG Tuberculosis (TB) Vaccine Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 GSBPL

      • 9.1.1 GSBPL Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Serum Institute of India

      • 9.2.1 Serum Institute of India Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 China National Biotec

      • 9.3.1 China National Biotec Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Sanofi Pasteur

      • 9.4.1 Sanofi Pasteur Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Intervax

      • 9.5.1 Intervax Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Merck

      • 9.6.1 Merck Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Japan BCG Lab

      • 9.7.1 Japan BCG Lab Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

     

    The List of Tables and Figures (Totals 100 Figures and 148 Tables)

    • Figure Immune BCG BCG Tuberculosis (TB) Vaccine market, 2015 - 2026 (USD Million)

    • Figure Therapy BCG BCG Tuberculosis (TB) Vaccine market, 2015 - 2026 (USD Million)

    • Figure Hospital market, 2015 - 2026 (USD Million)

    • Figure Clinic market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America BCG Tuberculosis (TB) Vaccine market, by country, 2015 - 2026 (USD Million)

    • Table North America BCG Tuberculosis (TB) Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table North America BCG Tuberculosis (TB) Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table North America BCG Tuberculosis (TB) Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. BCG Tuberculosis (TB) Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table U.S. BCG Tuberculosis (TB) Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table U.S. BCG Tuberculosis (TB) Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada BCG Tuberculosis (TB) Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Canada BCG Tuberculosis (TB) Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Canada BCG Tuberculosis (TB) Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Europe BCG Tuberculosis (TB) Vaccine market, by country, 2015 - 2026 (USD Million)

    • Table Europe BCG Tuberculosis (TB) Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Europe BCG Tuberculosis (TB) Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Europe BCG Tuberculosis (TB) Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. BCG Tuberculosis (TB) Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table U.K. BCG Tuberculosis (TB) Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table U.K. BCG Tuberculosis (TB) Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany BCG Tuberculosis (TB) Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Germany BCG Tuberculosis (TB) Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Germany BCG Tuberculosis (TB) Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France BCG Tuberculosis (TB) Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table France BCG Tuberculosis (TB) Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table France BCG Tuberculosis (TB) Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy BCG Tuberculosis (TB) Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Italy BCG Tuberculosis (TB) Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Italy BCG Tuberculosis (TB) Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain BCG Tuberculosis (TB) Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Spain BCG Tuberculosis (TB) Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Spain BCG Tuberculosis (TB) Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific BCG Tuberculosis (TB) Vaccine market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific BCG Tuberculosis (TB) Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific BCG Tuberculosis (TB) Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific BCG Tuberculosis (TB) Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China BCG Tuberculosis (TB) Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table China BCG Tuberculosis (TB) Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table China BCG Tuberculosis (TB) Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan BCG Tuberculosis (TB) Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Japan BCG Tuberculosis (TB) Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Japan BCG Tuberculosis (TB) Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India BCG Tuberculosis (TB) Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table India BCG Tuberculosis (TB) Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table India BCG Tuberculosis (TB) Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Latin America BCG Tuberculosis (TB) Vaccine market, by country, 2015 - 2026 (USD Million)

    • Table Latin America BCG Tuberculosis (TB) Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Latin America BCG Tuberculosis (TB) Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Latin America BCG Tuberculosis (TB) Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil BCG Tuberculosis (TB) Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Brazil BCG Tuberculosis (TB) Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Brazil BCG Tuberculosis (TB) Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico BCG Tuberculosis (TB) Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Mexico BCG Tuberculosis (TB) Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Mexico BCG Tuberculosis (TB) Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina BCG Tuberculosis (TB) Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Argentina BCG Tuberculosis (TB) Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Argentina BCG Tuberculosis (TB) Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table MEA BCG Tuberculosis (TB) Vaccine market, by country, 2015 - 2026 (USD Million)

    • Table MEA BCG Tuberculosis (TB) Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table MEA BCG Tuberculosis (TB) Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table MEA BCG Tuberculosis (TB) Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa BCG Tuberculosis (TB) Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table South Africa BCG Tuberculosis (TB) Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table South Africa BCG Tuberculosis (TB) Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria BCG Tuberculosis (TB) Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria BCG Tuberculosis (TB) Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria BCG Tuberculosis (TB) Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table GSBPL Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Serum Institute of India Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table China National Biotec Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Sanofi Pasteur Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Intervax Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Merck Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Japan BCG Lab Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US